SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

A sharp move has fueled speculation about a Novo Nordisk partnership or buyout, alongside heavy call trading and short-squeeze talk; traders dispute the rumors, and no deal is confirmed. The discussion also centers on VK2735, with ObesityWeek presentations approaching and Phase 3 trials underway.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Nvidia CEO Jensen Huangs departure fueled a speculative rotation into AMD as a potential AI-chip beneficiary, but traders are now debating the sharp reversal as profit-taking and weakness across semiconductors erased part of the rally. Some see a healthy pullback, while others question AMDs valuation and whether AI data-center spending can sustain the gains.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

The Federal Circuits affirmation of the PTABs invalidity ruling on Netlists 912 patent claim is driving the selloff, with traders weighing the loss of potential Google-related litigation upside against the companys existing licensing deals and other growth prospects. Some expect Netlist to seek rehearing, while others argue the claim had limited future value and the ruling does not undermine its broader business.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel pushed its planned prostate-cancer BLA submission for aglatimagene besadenovec from Q4 2026 to mid-2027, citing assay-refinement timelines and ongoing FDA discussions, prompting a sharp selloff. Traders are divided: many question managements execution and trustworthiness and worry about dilution, while others view the delay as a CMC issue rather than a setback to the clinical data and are buying the dip.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is under pressure after its quarterly report cited delayed third-party data-center capacity, a lower-end revenue outlook and higher buildout spending, heightening concerns about execution, financing and near-term growth; analyst target cuts have added to the selloff. Traders are split between viewing the decline as a buying opportunity given AI demand and expecting further weakness amid broader neocloud-sector pressure and doubts about delivery timelines and capital needs.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Attention centers on Webulls Q3 earnings report and whether its growth can support a recovery after China-related scrutiny and allegations weighed on the shares. Bulls are buying the dip and citing the companys expansion, while bears remain concerned about the negative headlines, dilution and persistent price weakness.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs departure has left traders debating Nvidias leadership succession and whether the transition could unsettle its strategy. The discussion is also focused on scrutiny of China chip exports and possible congressional investigations, while bulls argue that AI demand and the companys business remain strong.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arms quarterly results beat expectations, but shares are under pressure as traders focus on slower royalty growth and limited upside in the next-quarter outlook, with a broader semiconductor selloff adding pressure. The community is split between dip buyers citing AI and data-center demand and bearish traders questioning Arms high valuation and the durability of its royalty growth.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Ciscos post-earnings selloff is driving discussion: despite a strong quarter and raised full-year outlook tied to AI networking, traders are focused on lower gross margins from a hardware-heavy sales mix, slower product-order growth and a lower sequential revenue outlook. Bulls call the reaction overdone and point to AI demand and operating profitability, while bears see margin pressure and signs that growth may have peaked.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Phase 3 REGAL trial results for its GPS leukemia treatment are expected in November after the study reached its required 80th event, driving excitement around a major binary catalyst. Many traders are bullish and speculate about a short squeeze, while others caution that the results remain uncertain and could bring sharp volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Liberty Latin America Ltd. (LILA) Reports Q3 Loss, Lags Revenue Estimates

Liberty Latin America (LILA) delivered earnings and revenue surprises of -162.50% and -0.59%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Liberty Latin America Reports Q3 2026 Results

Liberty Latin America Ltd. (Liberty Latin America or LLA) (NASDAQ: LILA and LILAK, OTC Link: LILAB) today announced its financial and operating results for the three months (Q3) and nine months (YTD) ended September 30, 2026. President and CEO Balan Nair commented, In the third quarter, we...

LIBERTY LATIN AMERICA SCHEDULES INVESTOR CALL FOR THIRD QUARTER 2026 RESULTS

Liberty Latin America Ltd. (Liberty Latin America or the Company) (NASDAQ: LILA and LILAK, OTC Link: LILAB) today announced plans to release its third quarter 2026 results on Wednesday, November 4, 2026 after NASDAQ market close. You are invited to participate in its investor call, which will begin...

Transcript: Liberty Latin America Q2 2026 Earnings Conference Call

Liberty Latin America (NASDAQ:LILAK) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call.
This content is powered by Benzinga APIs. For comprehensive financialread more...

Media Tycoon John Malone Buys 37,082 More Liberty Latin America Preference Shares. What Does This Tell Investors?

Key PointsThe acquisition of 37,082 shares was executed at a weighted average price of $20.43, representing a total capital commitment of ~$758,000...

Billionaire Media Titan John Malone Buys 121,000 Liberty Latin America Shares. Should Investors Be Buyers Too?

Key Points~121,000 shares were purchased at an average price of $8.49 per share, representing a transaction value of ~$1.0 million...

Billionaire John Malone Buys 51K Liberty Latin America Shares. What Does This Mean for Investors?

Key PointsMalone acquired 50,696 shares at a weighted-average price of $8.50 per share, representing a total capital commitment of $430,916...

Liberty Latin America Reports Q2 2026 Results

Liberty Latin America Ltd. (Liberty Latin America or LLA) (NASDAQ: LILA and LILAK, OTC Link: LILAB) today announced its financial and operating results for the three months (Q2) and six months (YTD or H1) ended June 30, 2026. President and CEO Balan Nair commented, The second quarter represented...

LIBERTY LATIN AMERICA SCHEDULES INVESTOR CALL FOR SECOND QUARTER 2026 RESULTS

Liberty Latin America Ltd. (Liberty Latin America or the Company) (NASDAQ: LILA and LILAK, OTC Link: LILAB) today announced plans to release its second quarter 2026 results on Wednesday, August 5, 2026 after NASDAQ market close. You are invited to participate in its investor call, which will begin...

LIBERTY LATIN AMERICA ENTERS INTO SALE AGREEMENT IN PERU

Liberty Latin America Ltd. (Liberty Latin America or the Company) (NASDAQ: LILA and LILAK, OTC Link: LILAB) today announced that Liberty Latin America and its partners in Peru have entered into an agreement to sell their respective stakes in WOW Tel S.A.C. (WOW) to America Movil Peru S.A.C, a...

• Reported GAAP EPS of -$0.36 down -1900.00% YoY
• Reported revenue of $1.12B up 0.44% YoY

Liberty Latin America faces unresolved Puerto Rico debt negotiations ahead of the 2027 notes maturity, hurricane-related offline subscribers and revenue effects, and disclosure controls that remain ineffective.

Liberty Latin America delivered higher consolidated Adjusted OIBDA, reported revenue and Adjusted OIBDA increases in Costa Rica, and expects the Amdocs agreement to lower employee-related costs beginning in Q4 2026.

Liberty Latin America Ltd. is a holding company, which engages in the provision of fixed, mobile, and subsea telecommunications services. It operates through the following segments: C and W Carribean, C and W Panama, Liberty Networks, Liberty Puerto Rico, Liberty Costa Rica, and VTR. The company was founded in 1999 and is headquartered in Denver, CO.

Liberty Latin America Ltd - Ordinary Shares - Class A

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$9.73
Prev Close	$9.73
Open	$9.81
Dividend Yield	0.00%
50-Day Moving Average	$8.58
Beta	0.60
Avg. Volume	315,758.29
PE Ratio	-10.38

52-Week High	$10.33
52-Week Low	$4.58
Market Capitalization	$1.81B
EPS (Annual)	-$3.06
Price to Book	4.16
Revenue Per Employee	$493,577.78

Feed

News

Sentiment

Earnings

Fundamentals

Info

LILA Fundamentals